{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:44:33Z","timestamp":1791333873991,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00c3\u00a0 la Recherche dans l\u00e2\u0080\u0099Industrie et dans l\u00e2\u0080\u0099Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00c3\u00a0 la Recherche dans l\u00e2\u0080\u0099Industrie et dans l\u00e2\u0080\u0099Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.tips.2006.09.002","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T08:02:59Z","timestamp":1159257779000},"page":"566-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":365,"title":["Targeting tumor-associated carbonic anhydrase IX in cancer therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Anne","family":"Thiry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Dogn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Masereel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2006.09.002_bib1","series-title":"Carbonic Anhydrase. Its Inhibitors and Activators","first-page":"1","article-title":"Carbonic anhydrases: catalytic and inhibition mechanisms, distribution and physiological roles","author":"Supuran","year":"2004"},{"key":"10.1016\/j.tips.2006.09.002_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/BJ20051102","article-title":"Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase","volume":"392","author":"Hilvo","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2006.09.002_bib3","series-title":"Carbonic Anhydrase. Its Inhibitors and Activators","first-page":"255","article-title":"Cancer-related carbonic anhydrase isozymes and their inhibition","author":"Pastorekov\u00e1","year":"2004"},{"key":"10.1016\/j.tips.2006.09.002_bib4","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","article-title":"Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers","volume":"95","author":"Tureci","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2006.09.002_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0042-6822(92)90464-Z","article-title":"A novel quasi-viral agent, MaTu, is a two-component system","volume":"187","author":"Pastorekova","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.tips.2006.09.002_bib6","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.emboj.7600736","article-title":"Metabolon disruption: a mechanism that regulates bicarbonate transport","volume":"24","author":"Alvarez","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2006.09.002_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tips.2006.09.002_bib8","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.tips.2006.09.002_bib10","first-page":"6394","article-title":"Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix","volume":"61","author":"Loncaster","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/path.1120","article-title":"Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2","volume":"197","author":"Bartosova","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.tips.2006.09.002_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2006.09.002_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0168-8278(01)00193-3","article-title":"Transmembrane carbonic anhydrase, MN\/CA IX, is a potential biomarker for biliary tumours","volume":"35","author":"Saarnio","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tips.2006.09.002_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004180000181","article-title":"Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours","volume":"114","author":"Kivela","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.tips.2006.09.002_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1034\/j.1399-3003.1999.14d14.x","article-title":"Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma","volume":"14","author":"Vermylen","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.tips.2006.09.002_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0002-9440(10)65569-1","article-title":"Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN\/CA IX, with potential value as a marker of cell proliferation","volume":"153","author":"Saarnio","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2006.09.002_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0046-8177(97)90185-4","article-title":"MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker","volume":"28","author":"Turner","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tips.2006.09.002_bib18","first-page":"2362","article-title":"Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma","volume":"57","author":"McKiernan","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib19","first-page":"2827","article-title":"Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney","volume":"57","author":"Liao","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3748\/wjg.v9.i7.1398","article-title":"Carbonic anhydrase isozymes IX and XII in gastric tumors","volume":"9","author":"Leppilampi","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tips.2006.09.002_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ncb1144","article-title":"HIF activation by pH-dependent nucleolar sequestration of VHL","volume":"6","author":"Mekhail","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2006.09.002_bib22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1054\/bjoc.2000.1111","article-title":"Human tumour-associated cell adhesion protein MN\/CA IX: identification of M75 epitope and of the region mediating cell adhesion","volume":"82","author":"Zavada","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tips.2006.09.002_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with \u03b2-catenin","volume":"290","author":"Svastova","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tips.2006.09.002_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/geno.1996.0223","article-title":"Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships","volume":"33","author":"Opavsky","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.tips.2006.09.002_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.tips.2006.09.002_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00432-002-0374-x","article-title":"Effects of von Hippel\u2013Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma","volume":"128","author":"Ashida","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tips.2006.09.002_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2006.09.002_bib28","first-page":"1284","article-title":"Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism","volume":"8","author":"Helmlinger","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1357-4310(99)01615-9","article-title":"Causes and consequences of tumour acidity and implications for treatment","volume":"6","author":"Stubbs","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.tips.2006.09.002_bib30","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib31","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/13543776.13.10.1545","article-title":"Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity","volume":"13","author":"Supuran","year":"2003","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.tips.2006.09.002_bib32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/bjc.1997.201","article-title":"Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan","volume":"75","author":"Vukovic","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tips.2006.09.002_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","article-title":"Enhancement of chemotherapy by manipulation of tumour pH","volume":"80","author":"Raghunand","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tips.2006.09.002_bib34","first-page":"1549","article-title":"A carbonic anhydrase inhibitor as a potential modulator of cancer therapies","volume":"13","author":"Teicher","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tips.2006.09.002_bib35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bmcl.2004.12.053","article-title":"Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides \u2013 a new target for the design of antitumor and antiglaucoma drugs?","volume":"15","author":"Vullo","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2006.09.002_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0968-0896(00)00288-1","article-title":"Carbonic anhydrase inhibitors: sulfonamides as antitumor agents?","volume":"9","author":"Supuran","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tips.2006.09.002_bib37","first-page":"812","article-title":"Acetazolamide inhibits aquaporin-1 protein expression and angiogenesis","volume":"25","author":"Xiang","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tips.2006.09.002_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bmcl.2003.09.062","article-title":"Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX","volume":"14","author":"Abbate","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2006.09.002_bib39","first-page":"275","article-title":"Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis","volume":"1","author":"Yokoi","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2006.09.002_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1010608317361","article-title":"Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells","volume":"19","author":"Fukuoka","year":"2001","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.tips.2006.09.002_bib41","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0959-8049(01)00275-1","article-title":"E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo","volume":"37","author":"Ozawa","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tips.2006.09.002_bib42","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmcl.2005.04.058","volume":"15","author":"Winum","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2006.09.002_bib43","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1021\/ja061574s","article-title":"Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX","volume":"128","author":"Alterio","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2006.09.002_bib44","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2006.09.002_bib45","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis","volume":"48","author":"Cecchi","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2006.09.002_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/jm990479+","article-title":"Carbonic anhydrase inhibitors: synthesis of membrane-impermeant, low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2006.09.002_bib47","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1021\/jm0600287","article-title":"Indanesulfonamides as carbonic anhydrase inhibitors. Towards structure-based design of specific inhibitors of the tumor-associated isozyme CA IX","volume":"49","author":"Thiry","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2006.09.002_bib48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","article-title":"Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology","volume":"7","author":"Semenza","year":"2001","journal-title":"Trends Mol. Med."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614706002203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614706002203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:04:21Z","timestamp":1759050261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614706002203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0165614706002203"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2006.09.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2006.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}